BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 11602090)

  • 1. [Clinical predictors of long-term outcome of lithium prophylaxis in bipolar disorder].
    Garcia-López A; Ezquiaga E; Nieves P; Rodríguez-Salvanés F
    Actas Esp Psiquiatr; 2001; 29(5):327-32. PubMed ID: 11602090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effectiveness of lithium in the prophylaxis of affective disorders].
    Ezquiaga E; García-López A; Nieves P; Rodríguez-Salvanés F
    Actas Esp Psiquiatr; 2000; 28(3):156-60. PubMed ID: 11000697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Predictors of prophylactic response to lithium].
    Rohayem J; Baylé JF; Richa S
    Encephale; 2008 Sep; 34(4):394-9. PubMed ID: 18922242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylaxis of schizoaffective disorder with lithium or carbamazepine: outcome after long-term follow-up.
    Baethge C; Gruschka P; Berghöfer A; Bauer M; Müller-Oerlinghausen B; Bschor T; Smolka MN
    J Affect Disord; 2004 Apr; 79(1-3):43-50. PubMed ID: 15023479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcome of patients with bipolar disorder commenced on lithium prophylaxis during hospitalization: a complete 15-year register-based follow-up.
    Licht RW; Vestergaard P; Brodersen A
    Bipolar Disord; 2008 Feb; 10(1):79-86. PubMed ID: 18199244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term stability of cognitive impairment in bipolar disorder: a 2-year follow-up study of lithium-treated euthymic bipolar patients.
    Mur M; Portella MJ; Martínez-Arán A; Pifarré J; Vieta E
    J Clin Psychiatry; 2008 May; 69(5):712-9. PubMed ID: 18435565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lithium therapy for unipolar and bipolar depression among the middle-aged and older adult patient subpopulation.
    Lepkifker E; Iancu I; Horesh N; Strous RD; Kotler M
    Depress Anxiety; 2007; 24(8):571-6. PubMed ID: 17133442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lithium in the prophylaxis of recurrent affective disorders. Effectiveness of low plasma levels and predictors to clinical response (author's transl)].
    Faravelli C; Marchetti G; Benvenuti P; Cabras PL
    Riv Patol Nerv Ment; 1980; 101(6):261-71. PubMed ID: 6801749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Long-term lithium prophylaxis in the bipolar affective disorder].
    Suwalska A; Chłopocka-Woźniak M; Rybakowski J
    Psychiatr Pol; 2002; 36(6 Suppl):63-9. PubMed ID: 12647423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lithium treatment of bipolar affective disorders under naturalistic followup conditions.
    Goldberg JF; Harrow M; Leon AC
    Psychopharmacol Bull; 1996; 32(1):47-54. PubMed ID: 8927674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatments for late-life bipolar disorder.
    Aziz R; Lorberg B; Tampi RR
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):347-64. PubMed ID: 17296540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further evidence for a possible association between serotonin transporter gene and lithium prophylaxis in mood disorders.
    Serretti A; Malitas PN; Mandelli L; Lorenzi C; Ploia C; Alevizos B; Nikolaou C; Boufidou F; Christodoulou GN; Smeraldi E
    Pharmacogenomics J; 2004; 4(4):267-73. PubMed ID: 15111989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lithium maintenance: factors affecting outcome.
    Kocsis JH; Stokes PE
    Am J Psychiatry; 1979 Apr; 136(4B):563-6. PubMed ID: 426144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bipolar affective disorders and role of intraneuronal calcium. Therapeutic effects of the treatment with lithium salts and/or calcium antagonist in patients with rapid polar inversion].
    Manna V
    Minerva Med; 1991 Nov; 82(11):757-63. PubMed ID: 1766578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Who responds to prophylactic lithium therapy?
    Abou-Saleh MT
    Br J Psychiatry Suppl; 1993 Sep; (21):20-6. PubMed ID: 8217063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lithium in the long-term treatment of bipolar disorders.
    Kleindienst N; Greil W
    Eur Arch Psychiatry Clin Neurosci; 2003 Jun; 253(3):120-5. PubMed ID: 12904975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled lithium discontinuation in bipolar patients with good response to long-term lithium prophylaxis.
    Yazici O; Kora K; Polat A; Saylan M
    J Affect Disord; 2004 Jun; 80(2-3):269-71. PubMed ID: 15207941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Olanzapine: new indication. Prevention of bipolar disorder: unconvincing trials.
    Prescrire Int; 2005 Aug; 14(78):140-2. PubMed ID: 16106596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Classifying mood disorders by age-at-onset instead of polarity.
    Benazzi F
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):86-93. PubMed ID: 18992784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126).
    Vieta E; Suppes T; Eggens I; Persson I; Paulsson B; Brecher M
    J Affect Disord; 2008 Aug; 109(3):251-63. PubMed ID: 18579216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.